Influencing factor analysis and prediction model construction of dupilumab treatment adherence: a prospective cohort study in moderate-to-severe atopic dermatitis. [PDF]
Ouyang P +5 more
europepmc +1 more source
Spatiotemporal characteristics and influencing factor analysis of universities' technology transfer level in China: The perspective of innovation ecosystems. [PDF]
Fang H, Wang J, Yang Q, Liu X, Cao L.
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Intracranial aneurysm location: potential influencing factor in ruptures with internal carotid artery occlusion. [PDF]
Liu P +11 more
europepmc +1 more source
Exploration of Digital Creativity: Construction of the Multiteam Digital Creativity Influencing Factor Model in the Action Phase. [PDF]
Zhang J, Chen W, Xiao Y, Wang B.
europepmc +1 more source
Factors Influencing Histoplasmin Formation [PDF]
S B, Salvin, G A, Hottle
openaire +2 more sources
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Stress and influencing factor among children diagnosed with cancer at hospitals in Nepal: a cross-sectional study. [PDF]
Shahi SK +4 more
europepmc +1 more source
Modeling the Major Influencing Factor on Match Running Performance during the In-Season Phase in a Portuguese Professional Football Team. [PDF]
Teixeira JE +7 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

